Pierre Attali has extensive experience in the pharmaceutical and biotechnology sectors, holding leadership roles in various organizations since 1987. Currently a board member at QUANTIFICARE, Inc., involvement includes previous positions such as President at GETNA until June 2023, CEO and co-founder of SELEXEL, and CMO/Head of R&D at SENSORION. Attali also served as COO and CMO at BIOALLIANCE PHARMA - ONXEO, and held the CEO role at UROGENE and MOLECULAR ENGINES LABORATORIES. Earlier career milestones include co-founding OSMO and leading the Clinical Research and Development Department at Synthelabo. Educational background includes an MD and MSc in Medicine and Pharmacology from Paris-Sud University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices